Neuronal Molecule Makes Prostate Cancer More Aggressive
Researchers discover a potential therapeutic avenue against an aggressive form of prostate cancer.
Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer to progress into a highly aggressive form of the disease called neuroendocrine prostate cancer that currently has no effective treatment. The finding uncovers new avenues to explore for therapeutics to treat neuroendocrine prostate cancer.
"We have found novel pathways that promote neuroendocrine prostate cancer," says senior author Lucia R. Languino, PhD, a professor in the department of Pharmacology, Physiology and Cancer Biology and director of the Genetics, Genomics, and Cancer Biology PhD Program at Thomas Jefferson University. She and her team published the new research in the journal Scientific Reports.
Adenocarcinoma prostate cancers can progress into neuroendocrine prostate cancer. Until now, how this transition occurs has been a mystery.
To better understand how neuroendocrine prostate cancer develops, Dr. Languino and colleagues looked for biomarkers of the disease. In previous work, they discovered that a molecule known as aVb3 integrin is abundant in mice and humans with neuroendocrine prostate cancer, but missing in prostate adenocarcinoma.
To look for molecules unique to neuroendocrine prostate cancer, the researchers found that aVb3 integrin expression in prostate cancer cells bumped up the expression of a known marker of neuroendocrine prostate cancer and significantly increased the expression of a molecule called Nogo receptor 2 (NgR2).
The finding "was a big discovery," Dr. Languino says, who is also a researcher with the Sidney Kimmel Cancer Center – Jefferson Health. That's because NgR2 is a protein found in nerve cells, where it contributes to neuronal functions. It has never before been studied in cancer, of any kind.
Dr. Languino and her colleagues wanted to find out what this molecule, a neuronal protein, is doing in cancer.
An initial experiment revealed that NgR2 binds the aVb3 integrin. The scientists also saw that in mice with neuroendocrine prostate tumors, aVb3 integrin and NgR2 were both present in the primary tumor and in cancerous lesions that had formed in the lungs of the animals. A follow-up experiment made it clear that both aVb3 integrin and NgR2 are necessary for neuroendocrine prostate cancers.
When Dr. Languino and her team lowered the amount of NgR2 in neuroendocrine prostate cancer cells, neuroendocrine markers also decreased. The results suggest that NgR2 plays a role in the development of neuroendocrine prostate cancer. Lowering the amount of NgR2 also reduced the ability of cancer cells to grow and move, indicating that NgR2 may have a hand in cancer spreading to other parts of the body, in a process known as metastasis. Metastases are often what make cancers fatal.
"These two molecules, aVb3 integrin and NgR2, seem to create a combination that is lethal," Dr. Languino says.
She and her colleagues are now looking for a molecule or antibody that would block the effect of NgR2, or the aVb3 integrin/NgR2 complex, to inhibit their ability to promote neuroendocrine prostate cancer growth and development, and make the cancer more susceptible to therapy.
News
New breakthrough against radiation: Korean Scientists create revolutionary shield with nanotechnology
Korean Scientists develop new nanotechnology material capable of reducing radiation impacts in space missions, hospitals, and power plants. The search for more efficient protection technologies in extreme environments has just gained an important advance. Korean [...]
Scientists Just Discovered the Hidden Trick That Keeps Your Cells Alive
A strange bead-like motion inside cells may be the secret to keeping their DNA—and health—in balance. Mitochondria are often described as the power plants of the cell because they produce the energy cells need [...]
Scientists Discover Stem Cells That Could Regrow Teeth and Bone
Scientists just uncovered the cellular “blueprint” that could one day let us regrow real teeth. Researchers at Science Tokyo have uncovered two distinct stem cell lineages that play a central role in forming tooth [...]
Scientists Uncover Fatal Weakness in “Zombie Cells” Linked to Cancer
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own survival strategy against them. A new class of drugs takes advantage of a recently [...]
Bowel and Ovarian Cancers Are Dramatically Rising in Young Adults, Scientists Aren’t Sure Why
Cancer incidence is increasing, especially among younger adults, and current risk factors don’t fully account for the trend. Scientists suggest other underlying causes may be contributing. Cancer patterns in England are shifting in a [...]
New Immune Pathway Could Supercharge mRNA Cancer Vaccines
A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments. The arrival of mRNA vaccines against SARS-CoV-2 in 2020 marked a turning point in the COVID-19 pandemic. Today, [...]
Scientists Discover “Molecular Switch” That Fuels Alzheimer’s Brain Inflammation
A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression. The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer’s disease, growing evidence [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Forgotten Medicinal Plant Shows Promise in Fighting Dangerous Superbugs
A traditional medicinal plant, tormentil, shows promise against antibiotic-resistant bacteria in laboratory tests. Its compounds work by limiting bacterial growth and boosting antibiotic performance. Before the development of modern antibiotics, plant-based remedies were commonly [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New Research Finds Shocking Link Between Chili Peppers and Cancer
If you love spicy food, you are not alone. But scientists are taking a closer look at whether eating a lot of chili peppers could affect your cancer risk. Could your love of spicy [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Scientists Create “Neurobots” – Living Machines With Their Own Nervous Systems
Neurobots—xenobots with neurons—show self-organized nervous systems and enhanced behaviors, revealing new insights into how biology builds functional structures. In 2020, researchers at Tufts University developed tiny living structures known as xenobots using frog cells. These microscopic organisms [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Amazonian Chocolate Could Become the Next Superfood, Scientists Say
New research into Amazonian cocoa reveals that its value may extend beyond flavor alone. Chocolate from the Amazon is already known worldwide for its distinctive taste, but new research suggests it may offer even [...]
Nanobody repairs misfolded CFTR inside cells, boosting function in cystic fibrosis
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly into human cells and can repair the [...]
